Evidence map›Paper›PMID 29995557›Full record

ArticleAutophagy2018

USP14 regulates DNA damage repair by targeting RNF168-dependent ubiquitination.

Arishya Sharma, Turkeya Alswillah, Kamini Singh, Payel Chatterjee, Belinda Willard, Monica Venere, Matthew K Summers, Alexandru Almasan

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Guideline
  2. ADSCs-Exo ameliorates UVB-induced skin DNA damage via p62-RNF168-dependent histone ubiquitination.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Arishya Sharmaa Department of Cancer Biology , Lerner Research Institute, Cleveland Clinic , Cleveland , OH , USA.ORCID 0000-0003-2309-3791
Turkeya Alswillaha Department of Cancer Biology , Lerner Research Institute, Cleveland Clinic , Cleveland , OH , USA.
Kamini Singha Department of Cancer Biology , Lerner Research Institute, Cleveland Clinic , Cleveland , OH , USA.
Payel Chatterjeea Department of Cancer Biology , Lerner Research Institute, Cleveland Clinic , Cleveland , OH , USA.
Belinda Willardb Proteomics and Metabolomics Core , Lerner Research Institute, Cleveland Clinic , Cleveland , OH , USA.
Monica Venered Department of Radiation Oncology and the Comprehensive Cancer Center , The Ohio State University , Columbus , OH , USA.
Matthew K Summersd Department of Radiation Oncology and the Comprehensive Cancer Center , The Ohio State University , Columbus , OH , USA.
Alexandru Almasana Department of Cancer Biology , Lerner Research Institute, Cleveland Clinic , Cleveland , OH , USA.ORCID 0000-0002-8916-6650
Cleveland Clinic Lerner College of Medicine · USThe Ohio State University · USCleveland State University · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagyR01CA184137 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI ALMASAN, ALEXANDRU · 2015 to 2019
$1.8M
Dissecting functional interplay of deubiquitinases and the cell cycle machineryR01GM112895 · NIGMS · OHIO STATE UNIVERSITY · PI SUMMERS, MATTHEW K · 2015 to 2018
$1.2M
LTQ-Orbitrap Velos instrumentS10RR031537 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2011 to 2011
$600k
Leica TCS SP8 Confocal Microscope for a Core FacilityS10OD019972 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2015 to 2015
$544k
Spinning Disk Confocoal MicroscopeS10RR026820 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2010 to 2010
$500k
NCI NIH HHS P30 CA043703NCI NIH HHS R01 CA184137NCRR NIH HHS S10 RR026820NCRR NIH HHS S10 RR031537NIGMS NIH HHS R01 GM112895NIH HHS S10 OD019972
6 · The paper itself

Abstract

Recent reports have made important revelations, uncovering direct regulation of DNA damage response (DDR)-associated proteins and chromatin ubiquitination (Ubn) by macroautophagy/autophagy. Here, we report a previously unexplored connection between autophagy and DDR, via a deubiquitnase (DUB), USP14. Loss of autophagy in prostate cancer cells led to unrepaired DNA double-strand breaks (DSBs) as indicated by persistent ionizing radiation (IR)-induced foci (IRIF) formation for γH2AFX, and decreased protein levels and IRIF formation for RNF168, an E3-ubiquitin ligase essential for chromatin Ubn and recruitment of critical DDR effector proteins in response to DSBs, including TP53BP1. Consistently, RNF168-associated Ubn signaling and TP53BP1 IRIF formation were reduced in autophagy-deficient cells. An activity assay identified several DUBs, including USP14, which showed higher activity in autophagy-deficient cells. Importantly, inhibiting USP14 could overcome DDR defects in autophagy-deficient cells. USP14 IRIF formation and protein stability were increased in autophagy-deficient cells. Co-immunoprecipitation and colocalization of USP14 with MAP1LC3B and the UBA-domain of SQSTM1 identified USP14 as a substrate of autophagy and SQSTM1. Additionally, USP14 directly interacted with RNF168, which depended on the MIU1 domain of RNF168. These findings identify USP14 as a novel substrate of autophagy and regulation of RNF168-dependent Ubn and TP53BP1 recruitment by USP14 as a critical link between DDR and autophagy. Given the role of Ubn signaling in non-homologous end joining (NHEJ), the major pathway for repair of IR-induced DNA damage, these findings provide unique insights into the link between autophagy, DDR-associated Ubn signaling and NHEJ DNA repair. ABBREVIATIONS: ATG7: autophagy related 7; CQ: chloroquine; DDR: DNA damage response; DUB: deubiquitinase; HR: homologous recombination; IR: ionizing radiation; IRIF: ionizing radiation-induced foci; LAMP2: lysosomal associated membrane protein 2; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MIU1: motif interacting with ubiquitin; NHEJ: non homologous end-joining; PCa: prostate cancer; TP53BP1/53BP1: tumor protein p53 binding protein 1; RNF168: ring finger protein 168; SQSTM1/p62 sequestosome 1; γH2AFX/γH2AX: H2A histone family member X: phosphorylated, UBA: ubiquitin-associated; Ub: ubiquitin; Ubn: ubiquitination; USP14: ubiquitin specific peptidase 14.

Indexed as

Cell Line, TumorDNA Breaks, Double-StrandedDNA DamageDNA End-Joining RepairDNA RepairHEK293 CellsHumansPC-3 CellsProtein Interaction Domains and MotifsProtein Processing, Post-TranslationalRadiation, IonizingRNA, Small InterferingSignal TransductionUbiquitinationUbiquitin-Protein LigasesUbiquitin ThiolesteraseRNA, Small InterferingRNF168 protein, humanUbiquitin-Protein LigasesUbiquitin ThiolesteraseUSP14 protein, humanAutophagydeubiquitinaseDNA damage responseRNF168USP14

Identifiers

PMID29995557
PMCPMC6152509
OpenAlexW2865431834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.